Facebook Twitter LinkedIn Instagram Email Printer Google Plus

Sam Glick

Partner, Health & Life Sciences, Oliver Wyman

In this episode of the Oliver Wyman Health Podcast, we discuss a new joint professorship to advance population health management.

Dean, Jefferson College of Population Health
Executive Officer and President, Navvis
Partner, Health & Life Sciences, Oliver Wyman

Mental health is still considered separate from physical health. Let's merge them together as one.

Partner, Health & Life Sciences, Oliver Wyman

The center of healthcare's universe is changing from provider-centric to consumer-centric, and CEOs must follow suit.

Chief Executive Officer, Health Evolution
Partner, Health & Life Sciences, Oliver Wyman

Traditional retailers are now getting into the health business. What does it all mean, and where should corporate directors focus next?

Partner, Health & Life Sciences, Oliver Wyman

Cyberattacks pose potentially catastrophic physical and emotional risks for consumers. Protecting patient information will advance care delivery.

Program Director, Masters of Science in Management of Health Informatics & Analytics, The George Washington University
Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe

Human-robot interaction developed a decade ago at the MIT Media Lab is helping patients manage their chronic conditions thanks to a virtual companion named Mabu.

Founder and Chief Executive Officer, Catalia Health
Partner, Health & Life Sciences, Oliver Wyman

A look back at this year's Cost to Zero Moonshot panel at the StartUp Health Festival.

Partner, Health & Life Sciences, Oliver Wyman
Professor of Surgery and Health Policy, Johns Hopkins Medicine
CEO, Concerted Care Group
President & CEO, PeaceHealth

Healthcare loyalty programs have a lot to learn from the airline industry on how to manage consumer engagement and brand loyalty.

Partner, Health & Life Sciences, Oliver Wyman
President, American Airlines AAdvantage Program
Chief Executive Officer, Health Evolution

2018 has already seen transformational industry news. Here we dig deeper and analyze what the industry can expect in M&A, investments, pharma and much more.

Partner, Health & Life Sciences, Oliver Wyman
Managing Partner, Health & Life Sciences, Oliver Wyman

In a recent "Fast Company" article, Oliver Wyman's Sam Glick explains his views on what the creation of a new and powerful trifold healthcare company means for the greater industry.

Partner, Health & Life Sciences, Oliver Wyman

Insights in your inbox

Subscribe